SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

UBS Maintains Buy on Tenet Healthcare, Lowers Price Target to $32

UBS maintains Tenet Healthcare (NYSE:THC) with a Buy and lowers the price target from $49 to $32.

Benzinga · 05/14/2020 12:45

UBS maintains Tenet Healthcare (NYSE:THC) with a Buy and lowers the price target from $49 to $32.